By analyses on public clinical data, xenograft mouse models, and IHC and ISH staining of lung cancer tissue arrays, we confirm that AGO2 acetylation promotes cancer progression by increasing miR-19b maturation. The gene discussed is AGO2; the disease is lung carcinoma.